Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pregnant Woman With Single Pregnancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05829057
What this trial is testing

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

Who this might be right for
Esophagus CancerBladder CancerLiver Cancer+2 more
Zhejiang University 10
Early research (Phase 1)Study completedNCT02341599
What this trial is testing

Study of Pharmacokinetics of a Single IV Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects (MK-6183-001)

Who this might be right for
Healthy VolunteersRenal Impairment
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07117877
What this trial is testing

Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer

Who this might be right for
Platinum Resistant Ovarian CancerPlatinum Refractory Epithelial Ovarian CancerOvarian Cancer (OvCa)
Fudan University 33
Testing effectiveness (Phase 2)Study completedNCT02607553
What this trial is testing

Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA

Who this might be right for
Clear Cell Renal Cell Carcinoma
GenSpera, Inc. 2
Not applicableLooking for participantsNCT05677100
What this trial is testing

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Who this might be right for
Heart FailureCardiorenal SyndromeCardio-Renal Syndrome+5 more
Procyrion 320
Not applicableNot Yet RecruitingNCT07396792
What this trial is testing

Screening for Cardiac and Cardiac-associated Pathology Using Single-channel Electrocardiogram

Who this might be right for
Arterial HypertensionHeart Rhythm DisordersValvular Heart Diseases+5 more
I.M. Sechenov First Moscow State Medical University 4,000
Testing effectiveness (Phase 2)Ended earlyNCT02792192
What this trial is testing

Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants

Who this might be right for
Bladder Cancer
Hoffmann-La Roche 24
Early research (Phase 1)UnknownNCT03895788
What this trial is testing

Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hunan Cancer Hospital 24
Large-scale testing (Phase 3)Study completedNCT00002459
What this trial is testing

Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus

Who this might be right for
Endometrial CancerSarcoma
European Organisation for Research and Treatment of Cancer - EORTC 224
Testing effectiveness (Phase 2)Study completedNCT01809379
What this trial is testing

Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
Ruhr University of Bochum 69
Not applicableStudy completedNCT01334762
What this trial is testing

Efficacy of Letrozole and CC Alone in an IUI Program in Cases With Surgically Treated Minimal to Mild Endometriosis

Who this might be right for
Endometriosis
Mansoura University 136
Early research (Phase 1)Study completedNCT05491642
What this trial is testing

A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses

Who this might be right for
Chronic Kidney DiseaseHypertension
Bayer 56
Testing effectiveness (Phase 2)Ended earlyNCT01102218
What this trial is testing

A Safety Study of Pentoxifylline for the Treatment of Anemia

Who this might be right for
End Stage Renal Disease
Fresenius Medical Care North America 48
Early research (Phase 1)Study completedNCT05404542
What this trial is testing

To Evaluate Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Severe Renal Impairment Compared to Participants With Normal Renal Function

Who this might be right for
Renal Impairment
Cerevel Therapeutics, LLC 14
Post-approval studies (Phase 4)Study completedNCT03937869
What this trial is testing

Evaluate the Safety of a Single Oral Dose of Solosec™ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV

Who this might be right for
Bacterial Vaginoses
Lupin Research Inc 40
Testing effectiveness (Phase 2)UnknownNCT04068974
What this trial is testing

Camrelizumab /Apatinib for Recurrent Platinum-resistant Ovarian Cancer

Who this might be right for
Recurrent Platinum-resistant Ovarian Cancer
Peking Union Medical College Hospital 28
Testing effectiveness (Phase 2)Study completedNCT02706886
What this trial is testing

Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1

Who this might be right for
Primary Hyperoxaluria Type 1 (PH1)
Alnylam Pharmaceuticals 52
Testing effectiveness (Phase 2)Study completedNCT01305213
What this trial is testing

Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
National Cancer Institute (NCI) 107
Early research (Phase 1)Study completedNCT03250832
What this trial is testing

Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
Tesaro, Inc. 111
Early research (Phase 1)Study completedNCT01458847
What this trial is testing

Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
BioCis Pharma Ltd 12
Next Page